Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - atosiban - concentrate for solution for infusion - 37.5 mg/5ml - other gynecologicals; atosiban

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - atosiban - solution for injection in pre-filled syringe - 6.75 milligram(s) - other gynecologicals; atosiban

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

legacy pharmaceuticals switzerland gmbh - nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate - solution for topical use - 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bionorica se - agnus castus dry extract - tablets film-coated - 4mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bionorica se - agnus castus d1, blue cohosh d4, european cyclamen d4, strychnos ignatia d6, iris versicolor d2, tiger lily d3 - drops oral - 0.2g/g+ 0.1g/g+ 0.1g/g+ 0.1g/g+ 0.2g/g+ 0.1g/g

Malta - English - Medicines Authority

florealis ehf. síðumúla 25, 108 reykjavík, iceland - dry extract, of agnus, castus fruit - film-coated tablet - dry extract of agnus castus fruit 4 mg - other gynecologicals

Israel - English - Ministry of Health

rafa laboratories ltd - agni casti fructus - film coated tablets - agni casti fructus 20 mg - agni casti fructus - for the treatment of pms (premenstrual syndrome) complaints recurring monthly prior to menstruation in adults.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - atosiban - concentrate for soln for inf - 37.5 mg/5ml - atosiban - : other gynecologicals - atosiban accord injection is indicated to delay imminent pre-term birth in pregnant adult women with: - regular uterine contractions of at least 30 seconds duration at a rate of
4 per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of
50% - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate

European Union - English - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - atosiban (as acetate) - premature birth - other gynecologicals - atosiban is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds’ duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.

European Union - English - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - atosiban (as acetate) - premature birth - other gynecologicals - tractotile is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.